OpenAI announced in cooperation with Retro Biosciences startup a new artificial ielligence model named GPT-4b micro has taught that it aims to find a way to add 10 years to Human lifespanset
Sam Altman-backed startup Retro has been working with OpenAI on the project for almost a year, according to MIT Technology Review. The GPT-4b micro model attempts to re-engineer proteins that can transform human skin cells io youthful stem cells.
Retro believes that these proteins are a promising step towards building human organs and providing replaceme cells. This is the first OpenAI model focused on biological data, and the startup claims it can produce unexpected scieific results. According to this report, the connection between these 2 companies was not completely accideal; Because Sam Altman, CEO of OpenAI, personally 180 million dollars Coributed to Retro.
How to increase longevity with OpenAI artificial ielligence
Retro’s main goal of this project is to increase the natural life expectancy of humans by 10 years, and to realize it, “Yamanaka factors” (Yamanaka) studies. Yamanaka factors are a set of proteins that, when added to a human skin cell, create a young stem cell that can produce any other tissue in the body.
Retro and other companies such as Altos Labs have called this phenomenon a possible starting poi for rejuvenating animals, making organs for humans or providing replaceme cells, but the realization of this program is not very efficie. In fact, re-engineering them in the laboratory takes several weeks, and less than 1% of laboratory cells result in rejuvenation.
The GPT-4b micro AI model provides ways to re-engineer proteins to increase their function. OpenAI says based on preliminary test data of its model, researchers have been able to make Yamanaka’s 2 factors more than 50% more effective using the model’s suggestions.
Google also has the AlphaFold artificial ielligence model that can predict the structure of proteins. Of course, the models of these two companies have differe functions.
